Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. - Wikidata - wikimedia - TriplyDB

Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.

Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.

http://www.wikidata.org/entity/Q30447266

about

Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides.Prediction and analysis of the protein interactome in Pseudomonas aeruginosa to enable network-based drug target selection Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of Pseudomonas aeruginosa Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa A Putative ABC Transporter Permease Is Necessary for Resistance to Acidified Nitrite and EDTA in Pseudomonas aeruginosa under Aerobic and Anaerobic Planktonic and Biofilm Conditions.Determinants of exhaled breath condensate pH in a large population with asthma.Two-pronged survival strategy for the major cystic fibrosis pathogen, Pseudomonas aeruginosa, lacking the capacity to degrade nitric oxide during anaerobic respiration.T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa.Evidence for sigma factor competition in the regulation of alginate production by Pseudomonas aeruginosa.Inhibition of staphylococcal biofilm formation by nitrite.Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.A biophysical model for integration of electrical, osmotic, and pH regulation in the human bronchial epithelium.Contribution of cell elongation to the biofilm formation of Pseudomonas aeruginosa during anaerobic respiration Epistatic roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in coping with reactive oxygen species-induced DNA damage.Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes Acidosis potentiates the host proinflammatory interleukin-1β response to Pseudomonas aeruginosa infection Oral streptococci and nitrite-mediated interference of Pseudomonas aeruginosa.Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake.Simple sequence repeats together with mismatch repair deficiency can bias mutagenic pathways in Pseudomonas aeruginosa during chronic lung infection Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.Cytotoxicity of Pseudomonas secreted exotoxins requires OxyR expression An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.Inorganic nitrite therapy: historical perspective and future directions.Chronic rhinosinusitis pathogenesis.Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa.A novel siderophore system is essential for the growth of Pseudomonas aeruginosa in airway mucus Identification of essential genes of Pseudomonas aeruginosa for its growth in airway mucus.A Genetic Screen Reveals Novel Targets to Render Pseudomonas aeruginosa Sensitive to Lysozyme and Cell Wall-Targeting Antibiotics Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.Activation of cholera toxin production by anaerobic respiration of trimethylamine N-oxide in Vibrio cholerae Update in cystic fibrosis 2006 Network-assisted investigation of virulence and antibiotic-resistance systems in Pseudomonas aeruginosa Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis.Dual promoters of the major catalase (KatA) govern distinct survival strategies of Pseudomonas aeruginosa Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.

P2860

Q24673124-5A2EC093-B305-4468-9A20-295DAC3BB831 Q27311529-5F33B0A7-B897-4F90-82E1-D4D079B93315 Q28481505-B3470068-D135-4869-8E8B-DE5B77A4DB62 Q28486578-55BC9176-410B-4B60-8D6A-F284919F5235 Q28492464-F1FA0F58-9D79-4896-821D-7CA5EBBF0FB4 Q28492782-3D20A10B-14EF-43E5-9EA2-A193DCBF76DD Q28541355-9E9260B7-E229-4C86-880A-1A97FC9B67E5 Q29346826-2C4A2AF4-017E-4BAF-82B1-C3F96527043D Q30428487-58E92A29-B3A3-4B54-90D7-5A9D80CD24A7 Q30441279-87C29FD9-C6C8-40F5-B02C-C7000FED1CA9 Q30527825-75D7284B-5BBD-4B2D-AF6F-0AED7B358281 Q30974317-BD4135AA-C6FD-4D4B-B130-AFDB48A70F64 Q31132776-3D1D7B25-4D7D-463A-AF36-F60787C272BE Q33295154-6D41FDC7-6086-499C-A9AC-CA4C7AD31787 Q33522442-D93D2F80-BCDD-4F12-8EB9-8013D6EAAB17 Q33523793-7C4D1D4D-EF5C-4EC5-8B7E-15AB30DE5464 Q33795623-F8098367-460F-43D2-936B-64CB86043EF0 Q33803878-31827B9F-4590-45EF-AD63-5563EDFA3889 Q33886303-6C0BCD61-A64D-414A-9FD6-A22475AD9EFC Q34480377-9AD0A7D6-1C54-4E10-89A4-9CB40453CFDF Q34596066-C0D8910C-4EF1-49EF-A312-D4647A0C0BBC Q34889601-6717EBBC-FF69-4803-B075-1BD703AB575A Q34932787-9880EBFF-92CC-432D-8194-69ED4C0C9A4C Q35053587-1460ABBD-392A-49D9-B5F0-7A5799AB68C4 Q35055371-0DD31070-3860-45BC-B517-FC7A538E1FAA Q35185082-626C647F-082C-4401-906B-5819A1A64DF5 Q35534747-8F940C9F-8404-4D2E-8E67-E7CAF0BF74A7 Q35552149-1BCC36F2-DF69-4C45-A26C-5D7995625438 Q35865515-5812DF60-3CAC-4A53-B5B8-75D1C6E0743B Q35944028-8FC764D6-FD2B-40BB-8622-8989D7CC2145 Q36134138-F2890FE4-C0B2-460B-AA0C-86E34D73F95C Q36236143-CBE46E3F-4A4A-44F0-86A7-7624A6BD03AC Q36309883-A35220A4-326C-4CF8-8710-B8426488FB8A Q36346231-6315774D-7690-4EC4-92A1-C53F26164A80 Q36407925-BBEF765A-6F7F-414B-A381-CC49B7FFA461 Q36779226-7119A1B9-6260-43A7-A057-56D1A604FDDB Q36914772-B0DAF02A-83A9-4C4F-BDF5-4E038A346D44 Q36999096-3AE81B69-373B-43B5-8DDB-5EC684973AEF Q37153801-5ADDE178-CE5F-452E-916B-0950749AAF3D Q37263313-484994EF-3428-4BF1-93CB-D1C551E591D7

P2860

Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.

http://www.wikidata.org/entity/Q30447266

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Anaerobic killing of mucoid Ps ...... ic fibrosis airway conditions.

@ast

Anaerobic killing of mucoid Ps ...... ic fibrosis airway conditions.

@en

type

label

Anaerobic killing of mucoid Ps ...... ic fibrosis airway conditions.

@ast

Anaerobic killing of mucoid Ps ...... ic fibrosis airway conditions.

@en

prefLabel

Anaerobic killing of mucoid Ps ...... ic fibrosis airway conditions.

@ast

Anaerobic killing of mucoid Ps ...... ic fibrosis airway conditions.

@en

P1433

Q30447266-42CF85FB-D27A-4BE4-BE89-D095550D9731

P1476

Q30447266-1C306465-0F94-4540-9DB9-120E580F1B5A

P2093

Q30447266-1CBF1229-8274-4D4F-B2DD-DF5C2D3A52BB

Q30447266-3642C96D-E95F-4EEB-80D4-DA88D681D3B6

Q30447266-388A5235-52DE-4CEA-89D2-2412EB125CF2

Q30447266-43CFC031-B630-4E07-99FF-BEF294145C9B

Q30447266-6674D45E-89F2-4207-9525-0992E4319778

Q30447266-79C4F6F8-6DE2-48D6-9653-196E4228562A

Q30447266-B263A308-1ACF-4FD6-994E-34F20D05C240

Q30447266-BB0E38F5-5888-4DE0-B0EE-3F97087893AE

Q30447266-D85F6B3E-D118-4154-87C4-46E4ED9EDC56

Q30447266-E5192959-4A87-47DE-98AE-0474A0ACBF84

P2860

Q30447266-05C8F1A9-4F7E-461C-8637-4EB4E568ECDB

Q30447266-0DFF713D-D9F1-444A-AEFC-51E18A527152

Q30447266-1239CDFD-D5E4-494B-817A-8EA24B1C466F

Q30447266-158ECF5C-0621-47A9-9B24-219754D6200D

Q30447266-16804400-091A-435F-9BDF-2AD88B22B410

Q30447266-1778DBD8-5FA0-4FC4-AF31-7A56923FDDC5

Q30447266-178407D7-6AC1-4CFB-975A-16812643697F

Q30447266-2028A2ED-C73F-4E2B-BE9D-8824F8B14CC9

Q30447266-247539FC-AF0F-4712-872B-E2F000A41CEE

Q30447266-2B4FEAA5-593B-400F-BD9B-52009D42F6CA

P304

Q30447266-0FB5C12A-FD5B-474D-8054-4B70BEF16E7B

P31

Q30447266-52F07DF6-06B1-4C32-87FA-359E8C45BD5E

P356

Q30447266-49BAF23F-9AC3-4D81-B756-9DF120BB153E

P407

Q30447266-C90E8C9E-B860-4664-8B91-2FDB82D245A8

P433

Q30447266-0E740B51-66B3-4992-AE8A-F0487B3440A0

P478

Q30447266-8F71B754-4011-4C6F-A5ED-EC6B174EE6CB

P50

Q30447266-9DA3993B-9EAB-4429-86D7-FB5399AFF57A

Q30447266-F9AFD882-84B0-454E-B6F0-DC18D5C5B482

P577

Q30447266-57AA2ECE-9E1E-4710-8340-00BD199DFEED

P5875

Q30447266-2316F852-04B3-4994-8678-FC7411215F47

P698

Q30447266-637B1CFB-B65D-4E12-A668-67038B30DFCD

P921

Q30447266-4AA7115E-723B-44C7-9584-F757BD080265

Q30447266-4BF4DBD6-7075-4C6B-A389-B04A0053C883

P932

Q30447266-63416715-1702-4393-A564-86EB19DFAD2E

P356

P1433

Journal of Clinical Investigation

P1476

Anaerobic killing of mucoid Ps ...... tic fibrosis airway conditions

@en

P2093

Ahmet C Karabulut

http://www.w3.org/2001/XMLSchema#string

Benjamin Gaston

http://www.w3.org/2001/XMLSchema#string

Daniel J Hassett

http://www.w3.org/2001/XMLSchema#string

David Speert

http://www.w3.org/2001/XMLSchema#string

Gee W Lau

http://www.w3.org/2001/XMLSchema#string

Jane L Burns

http://www.w3.org/2001/XMLSchema#string

Joel E Mortensen

http://www.w3.org/2001/XMLSchema#string

Michael J Schurr

http://www.w3.org/2001/XMLSchema#string

Ray Coakley

http://www.w3.org/2001/XMLSchema#string

Richard C Boucher

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen

Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development

A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans

Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

Endogenous airway acidification. Implications for asthma pathophysiology.

Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy.

P304

436-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI24684

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Garry R. Buettner

P577

2006-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7333722

http://www.w3.org/2001/XMLSchema#string

P698

16440061

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

Pseudomonas aeruginosa

P932

1350997

http://www.w3.org/2001/XMLSchema#string